Zeng Yi, Zheng Bo, Shen Bin, Yang Jing, Zhou Zongke, Kang Pengde, Pei Fuxing
Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, 37# Guoxue Road, Chengdu, 610041, Sichuan, People's Republic of China,
J Orthop Sci. 2015 Mar;20(2):357-63. doi: 10.1007/s00776-014-0678-0. Epub 2014 Dec 23.
Despite the theoretical advantages of ceramic-on-metal (CoM) bearings observed in laboratory settings, limited clinical data are available to support in vitro results. Our present study prospectively investigated the clinical results, serum metal ion levels, inflammatory factor levels, and liver-kidney function in a cohort of patients who received total hip arthroplasty (THA) with CoM bearings.
The cohort comprised 82 THAs in 71 patients (41 men and 30 women), with a mean age of 54 (range 22-77) years. The mean follow-up was four years. All patients completed pre- and postoperative clinical assessment using the Harris Hip Score, Short Form-12, Western Ontario and McMaster Universities Osteoarthritis Index, and radiographic analysis. The serum metal ion levels of cobalt, chromium, molybdenum, and titanium were measured using high-resolution inductively coupled plasma mass spectrometry, and were compared with normal reference values. Inflammatory factors including C-reactive protein, erythrocyte sedimentation, and interleukin-6 levels, and liver-kidney function including alanine aminotransferase, aspartate aminotransferase, total bilirubin, creatinine, and blood urea nitrogen, were measured in our hospital clinical key laboratory.
At the end of the follow-up period, all clinical assessments showed a statistically significant improvement. Although the inflammatory factor levels and liver-kidney function were within normal ranges, the serum levels of metal ion were significantly elevated compared with normal values: cobalt, 2.8 μg/L; chromium, 2.2 μg/L; molybdenum, 0.9 μg/L; and titanium, 2.1 μg/L. Spearman's correlation analysis showed an association between cobalt, chromium, and titanium metal ion levels and BMI values.
Our study demonstrated that the use of a CoM THA was clinically effective and that metal ion levels were significantly elevated at midterm follow-up. Whether the elevated metal ion levels may reduce adverse reactions is unknown, and long-term follow-up is needed.
尽管在实验室环境中观察到金属对陶瓷(CoM)轴承具有理论优势,但支持体外研究结果的临床数据有限。我们目前的研究前瞻性地调查了接受CoM轴承全髋关节置换术(THA)的一组患者的临床结果、血清金属离子水平、炎症因子水平和肝肾功能。
该队列包括71例患者(41例男性和30例女性)的82例THA,平均年龄为54岁(范围22 - 77岁)。平均随访时间为四年。所有患者均使用Harris髋关节评分、简明健康状况调查问卷12项、西安大略和麦克马斯特大学骨关节炎指数完成术前和术后临床评估以及影像学分析。使用高分辨率电感耦合等离子体质谱法测量血清中钴、铬、钼和钛的金属离子水平,并与正常参考值进行比较。在我院临床重点实验室测量包括C反应蛋白、红细胞沉降率和白细胞介素 - 6水平在内的炎症因子以及包括谷丙转氨酶、谷草转氨酶、总胆红素、肌酐和血尿素氮在内的肝肾功能。
在随访期结束时,所有临床评估均显示出统计学上的显著改善。尽管炎症因子水平和肝肾功能在正常范围内,但与正常值相比,金属离子的血清水平显著升高:钴为2.8μg/L;铬为2.2μg/L;钼为0.9μg/L;钛为2.1μg/L。Spearman相关性分析显示钴、铬和钛金属离子水平与体重指数值之间存在关联。
我们的研究表明,使用CoM全髋关节置换术在临床上是有效的,并且在中期随访时金属离子水平显著升高。金属离子水平升高是否会减少不良反应尚不清楚,需要进行长期随访。